Literature DB >> 436208

Mechanism of propranolol withdrawal phenomena.

S Nattel, R E Rangno, G Van Loon.   

Abstract

Nine patients on chronic treatment with propranolol for essential hypertension for 3 months or longer were studied after abrupt discontinuation of the drug. Each patient demonstrated transient supersensitivity to the chronotropic effects of isoproterenol, beginning 2--6 days (median 4 days) after propranolol withdrawal, lasting for 3--13 days (median 6 days), with the maximum sensitivity on day 6. A significantly lower dose of isoproterenol was necessary to increase heart rate 25 beats/min on day 6 (median dose 1.2 microgram, range 0.3--3.4 microgram) compared with after day 14, when sensitivity had stabilized (median dose 2.3 microgram, range 1.4--7.6 microgram). Six patients had transient symptoms (headache, chest pain, palpitations and sweating) after abrupt propranolol withdrawal, coinciding with supersensitivity to isoproterenol in five. Transient increases in plasma catecholamines and blood pressures and sustained increases in heart rate occurred during the period of isoproterenol supersensitivity in most patients, and may have contributed to symptoms noted. The delayed onset and potentially long duration of beta-adrenergic supersensitivity after abrupt propranolol withdrawal have important clinical implications.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 436208     DOI: 10.1161/01.cir.59.6.1158

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  41 in total

1.  Beta-blocker withdrawal syndrome.

Authors:  C T Dollery; T J Maling
Journal:  Br Med J       Date:  1979-10-27

2.  Dr Walker reply.

Authors:  P R Walker
Journal:  Br Heart J       Date:  1986-08

3.  Dr Walker reply.

Authors:  P R Walker
Journal:  Br Heart J       Date:  1986-01

Review 4.  Optimal treatment of angina in older patients.

Authors:  R N Doughty; N Sharpe
Journal:  Drugs Aging       Date:  1996-05       Impact factor: 3.923

Review 5.  2014 AATS guidelines for the prevention and management of perioperative atrial fibrillation and flutter for thoracic surgical procedures.

Authors:  Gyorgy Frendl; Alissa C Sodickson; Mina K Chung; Albert L Waldo; Bernard J Gersh; James E Tisdale; Hugh Calkins; Sary Aranki; Tsuyoshi Kaneko; Stephen Cassivi; Sidney C Smith; Dawood Darbar; Jon O Wee; Thomas K Waddell; David Amar; Dale Adler
Journal:  J Thorac Cardiovasc Surg       Date:  2014-06-30       Impact factor: 5.209

Review 6.  Cardiovascular drug withdrawal syndromes. A potential problem with calcium antagonists?

Authors:  E B Raftery
Journal:  Drugs       Date:  1984-11       Impact factor: 9.546

7.  Beta-adrenoceptor blocking drugs and partial agonist activity. Is it clinically relevant?

Authors:  D G McDevitt
Journal:  Drugs       Date:  1983-04       Impact factor: 9.546

8.  Comparison of withdrawal phenomena after propranolol, metoprolol and pindolol.

Authors:  R E Rangno; S Langlois
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

9.  Abrupt withdrawal of atenolol in patients with severe angina. Comparison with the effects of treatment.

Authors:  P R Walker; A J Marshall; S Farr; B Bauminger; G Walters; D W Barritt
Journal:  Br Heart J       Date:  1985-03

10.  Coronary vasomotor and clinical effects of nifedipine in effort, mixed and Prinzmental angina.

Authors:  A Polese; N De Cesare; A Bartorelli; F Fabbiocchi; A Loaldi; P Montorsi; M D Guazzi
Journal:  Int J Card Imaging       Date:  1988
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.